Emergent BioSolutions (EBS) SVP reports 1,741-share tax withholding on RSU vesting
Rhea-AI Filing Summary
Emergent BioSolutions Inc. Senior Vice President of Bioservices William Hartzel reported a routine tax-related share disposition. On June 8, 2026, 1,741 shares of common stock were withheld at $8.00 per share to cover taxes from the vesting and settlement of restricted stock units. After this withholding, Hartzel directly held 185,558 shares of Emergent BioSolutions common stock. This was not an open-market sale but an automatic tax-withholding mechanism tied to equity compensation.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 1,741 shares
Net Sell
1 txn
Insider
Hartzel William
Role
SVP, Bioservices
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 1,741 | $8.00 | $14K |
Holdings After Transaction:
Common Stock — 185,558 shares (Direct)
Footnotes (1)
- F1. Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units
Key Figures
Shares withheld for taxes: 1,741 shares
Withholding price per share: $8.00 per share
Shares held after transaction: 185,558 shares
3 metrics
Shares withheld for taxes
1,741 shares
Tax-withholding disposition on June 8, 2026
Withholding price per share
$8.00 per share
Value used for tax-withholding shares
Shares held after transaction
185,558 shares
Direct ownership after June 8, 2026 Form 4
Key Terms
tax-withholding disposition, restricted stock units, Form 4
3 terms
tax-withholding disposition financial
"A total of 1,741 Emergent BioSolutions common shares were withheld for William Hartzel’s tax obligations."
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
restricted stock units financial
"shares were connected to the vesting and settlement of restricted stock units granted as part of his compensation package."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Form 4 regulatory
"This post-transaction balance shown in the Form 4 indicates that the withholding affected only a small portion of his overall share position."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Emergent BioSolutions (EBS) report for William Hartzel?
Emergent BioSolutions reported a tax-related share disposition by SVP, Bioservices, William Hartzel. On June 8, 2026, 1,741 common shares were withheld to cover taxes from vesting restricted stock units, a standard equity compensation mechanism rather than an open-market stock sale.
Was William Hartzel’s Emergent BioSolutions (EBS) Form 4 a stock sale on the market?
The Form 4 does not show an open-market sale by William Hartzel. Instead, 1,741 shares were withheld by the company to pay taxes on vested restricted stock units, which is a routine administrative transaction associated with equity compensation programs.
What does transaction code F mean in the Emergent BioSolutions (EBS) Form 4?
Transaction code F indicates shares were used to pay exercise price or tax liability. In this case, 1,741 Emergent BioSolutions shares were withheld to satisfy taxes from the vesting and settlement of restricted stock units, rather than being sold in the open market.